160 related articles for article (PubMed ID: 2667702)
1. The human skin mast cell.
Benyon RC
Clin Exp Allergy; 1989 Jul; 19(4):375-87. PubMed ID: 2667702
[TBL] [Abstract][Full Text] [Related]
2. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli.
Benyon RC; Robinson C; Church MK
Br J Pharmacol; 1989 Jul; 97(3):898-904. PubMed ID: 2474353
[TBL] [Abstract][Full Text] [Related]
3. Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells.
Cerrato S; Brazis P; della Valle MF; Miolo A; Puigdemont A
Vet Immunol Immunopathol; 2010 Jan; 133(1):9-15. PubMed ID: 19625089
[TBL] [Abstract][Full Text] [Related]
4. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells.
Robinson C; Benyon C; Holgate ST; Church MK
J Invest Dermatol; 1989 Sep; 93(3):397-404. PubMed ID: 2504819
[TBL] [Abstract][Full Text] [Related]
5. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
Holgate ST; Burns GB; Robinson C; Church MK
J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
[TBL] [Abstract][Full Text] [Related]
6. Interaction of neuropeptides with human mast cells.
Church MK; Lowman MA; Robinson C; Holgate ST; Benyon RC
Int Arch Allergy Appl Immunol; 1989; 88(1-2):70-8. PubMed ID: 2468622
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin.
Okayama Y; Benyon RC; Lowman MA; Church MK
Allergy; 1994 Apr; 49(4):246-53. PubMed ID: 7518654
[TBL] [Abstract][Full Text] [Related]
8. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol preferentially inhibits IgE-dependent PGD2 biosynthesis but enhances TNF production from human skin mast cells.
Shirley D; McHale C; Gomez G
Biochim Biophys Acta; 2016 Apr; 1860(4):678-85. PubMed ID: 26777630
[TBL] [Abstract][Full Text] [Related]
10. Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.
Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén SE; Nilsson G; Dahlén B
Clin Exp Allergy; 2017 Jul; 47(7):909-917. PubMed ID: 28258965
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 potentiates FcεRI-induced PGD
McHale C; Mohammed Z; Deppen J; Gomez G
Biochim Biophys Acta Gen Subj; 2018 May; 1862(5):1069-1078. PubMed ID: 29410184
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [DArg0-Hyp3-DPhe7]bradykinin.
Cohan VL; MacGlashan DW; Warner JA; Lichtenstein LM; Proud D
Biochem Pharmacol; 1991 Jan; 41(2):293-300. PubMed ID: 1703413
[TBL] [Abstract][Full Text] [Related]
13. Structural and secretory characteristics of bovine lung and skin mast cells: evidence for the existence of heterogeneity.
Hunt TC; Campbell AM; Robinson C; Holgate ST
Clin Exp Allergy; 1991 Mar; 21(2):173-82. PubMed ID: 1710530
[TBL] [Abstract][Full Text] [Related]
14. Mediator secretion from human skin mast cells provoked by immunological and non-immunological stimulation.
Church MK; Okayama Y; el-Lati S
Skin Pharmacol; 1991; 4 Suppl 1():15-24. PubMed ID: 1722414
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.
Church MK; Hiroi J
Br J Pharmacol; 1987 Feb; 90(2):421-9. PubMed ID: 2435353
[TBL] [Abstract][Full Text] [Related]
16. General anaesthetics induce only histamine release selectively from human mast cells.
Stellato C; Casolaro V; Ciccarelli A; Mastronardi P; Mazzarella B; Marone G
Br J Anaesth; 1991 Dec; 67(6):751-8. PubMed ID: 1722691
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses.
Wagner B; Miller WH; Erb HN; Lunn DP; Antczak DF
Vet Immunol Immunopathol; 2009 Nov; 132(1):53-61. PubMed ID: 19836083
[TBL] [Abstract][Full Text] [Related]
18. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
el-Lati SG; Dahinden CA; Church MK
J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of chronic urticaria.
Kaplan AP; Greaves M
Clin Exp Allergy; 2009 Jun; 39(6):777-87. PubMed ID: 19400905
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin.
Cohan VL; Undem BJ; Fox CC; Adkinson NF; Lichtenstein LM; Schleimer RP
Am Rev Respir Dis; 1989 Oct; 140(4):951-4. PubMed ID: 2478059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]